ADAM10 and neoplasm: Regulating the activities of ADAM10 and ADAM17 to inhibit the shedding of MICA/B on cancer cells can significantly promote the degranulation of peripheral, liver, and tumor-infiltrating NK cells and the production of IFN-γ, enhancing the anti-tumor activity of NK cells [8].